Liver function in postmenopausal women on estrogen-androgen hormone replacement therapy: A meta-analysis of eight clinical trials

Menopause

Volumn 6, Issue 3, 1999, Pages 216-224

  Gitlin, Norman ^a   Korner, Paul ^b   Yang, Hwa Ming ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Androgens; Esterified estrogen methyltestosterone; Hepatic biochemical markers; Hepatotoxicity; Hormone replacement therapy; Menopause

Indexed keywords

CONJUGATED ESTROGEN; ESTRATEST; METHYLTESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; FEMALE; HUMAN; LIVER FUNCTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

EID: 0032824877     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-199906030-00007     Document Type: Article

References (26)

1. Data Base. Solvay Pharmaceuticals, Marietta, Georgia, USA.
2. Speroff L, Glass R, Kase N. Clinical gynecologic endocrinology and infertility, Ed. 5. Baltimore: Williams & Wilkins, 1994;590.
3. Meldrum DL, Davidson BJ, Tataryn IV, et al. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 1981;57:624.
4. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 1976;42:247.
5. Barrett-Conner E, Timmons G, Young R, Wiita B. Interim safety analysis of a 2-year study comparing oral estrogen-androgen and conjugated estrogens in surgically menopausal women. J Womens Health 1996;5:593-602.
6. Burger HC, Hailes J, Menelaus M, et al. The management of persistent menopausal symptoms with estradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas 1984;6:351.
7. Greenblatt RB, Bardield WE, Garner JF, et al. Evaluation of an androgen, and estrogen, an estrogen-androgen combination, and a placebo in the treatment of menopause. J Clin Endocrinol 1950;10:1547-9.
8. Sherwin BB, Gelfand MM. Transactions of the 40th annual meeting of the Society of Obstetricians and Gynecologists of Canada: differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985;51:153-6.
9. Davis SR, McCloud R, Strauss BJG, et al. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-31.
10. Hickock LR, Toomey C, Speroff L. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women. Obstet Gynecol 1993;82:919-21.
11. Mocquot P, Moricard R. Bull Soc Gynecol Obstet 1936;25:787.
12. Salmon UJ, Geist SH. J Endocrinol 1943; 3: 235-8.
13. Nathanson IT, Towne LE. The urinary excretion of estrogens, androgens and FSH after the administration of testosterone to human female castrates. Endocrinology 1939;25:754-8.
14. Berg G, Gottwall T, Hammar M, et al. Climacteric symptoms among women aged 60-62 in Linköping, Sweden, in 1986. Maturitas 1988;10:193-9.
15. Casson PR, Elkind-Hirsch KE, Buster JE, et al. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 1997;90:995-8.
16. Dennerstein L. Well-being, symptoms and the menopausal transition. Maturitas 1996;23:147-57.
17. Bachman G. Role of androgens in the menopause: a panel of physician experts examines the role of androgen co-therapy. OBG Management (Suppl.)1998;July:4-5.
18. Gelfand MM. Treating menopausal symptoms with estrogen and androgen preparations. Contemp OBG 1994;39(5):31-6.
19. Watts MB, Notelovitz M, Timmons MC, et al. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995;85:529-37.
20. Honoré EK, Williams JK, Adams MR, et al. Methyltestosterone does not diminish the beneficial effects of estrogen replacement therapy on coronary artery reactivity in cynomolgus monkeys. Menopause 1996;3:20-6.
21. Yue P, Chatterjee K, Beale C, et al. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 1995;91:1154-60.
22. Raisz LG, Wiita B, Artis A, et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1996;81:37-43.
23. Simon JA, Klaiber E, Wiita B, et al. Double-blind comparison of two doses of estrogen and estrogen-androgen therapy in naturally postmenopausal women: neuroendocrine, psychological and psychosomatic effects. Fertil Steril 1996;66:S71.
24. Greenblatt RB. Androgenic therapy in gynecology. JAMA 1942;2:665-6.
25. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987;49:397-409.
26. Sarrel PM, Dobey B, Wiita B. Sexual behavior and neuroendocrine responses to estrogen and estrogen-androgen in postmenopausal women dissatisfied with estrogen alone therapy. J Reprod Med 1998;43:847-56.